Relapse was declared when, during a clinical remission, initial symptoms such as anemia or thrombocytopenia occurred, as well as in presence of abrupt or slowly progressive worsening of clinical status, or insidious alterations in laboratory values (i.e., ADAMTS13 activity < 10%) [51]. This evidence concerns the gene ADAMTS13 and Thrombocytopenia.